Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase AMP‑activated catalytic subunit alpha 2 (AMPKα₂) is one of two catalytic isoforms forming part of the heterotrimeric AMP‑activated protein kinase complex. This enzyme acts as a central regulator (“energy sensor”) maintaining cellular energy homeostasis by responding to changes in intracellular ATP/AMP ratios. Upon activation—typically triggered by increased cellular stress or low nutrient states—AMPKα₂ phosphorylates multiple downstream targets involved in catabolic processes that generate ATP while inhibiting anabolic processes consuming ATP. The PRKAA₂ gene encodes this isoform; it is expressed broadly but shows tissue-specific functions distinct from its close homolog AMPKα₁. Dysregulation has been implicated in metabolic diseases such as diabetes and obesity, cardiovascular pathologies, certain cancers where it can promote tumor immune escape via T-cell exhaustion mechanisms, neurodegeneration linked to impaired bioenergetics, and other conditions involving altered cell metabolism.
Drugs targeting this molecule typically act by one or more of the following mechanisms: – Allosteric activation by mimicking AMP binding to regulatory γ subunits – Indirect activation through upstream kinases that phosphorylate Thr174 on the α‑2 catalytic domain – Inhibition or modulation of downstream targets regulated by AMPK phosphorylation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase AMP-activated catalytic subunit alpha 2 (AMPKα2).